SanofiSNYNF
13F holders, Q1 2026 (March 31)2holders
0new positions
0sold out
$95.58avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Sanofi (SNYNF) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were Generali Investments CEE, investicni spolecnost, a.s. ($2.8M) and GAMMA Investing LLC ($29K).
- Company
- Sanofi
- CUSIP
- F5548N101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 2,220 shares sold, net −2,220 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Generali Investments CEE, investicni spolecnost, a.s. | 0.14% | Reduce -7.2% | 28,775 | $2.8M |
| GAMMA Investing LLC | 0.00% | No change | 306 | $29K |
"% of holder's portfolio" is SNYNF's weight in each manager's 13F, not the share of Sanofi the manager owns.